The impact of interval from surgery to chemotherapy and age in advanced-stage ovarian cancer: A GOG ancillary study.

被引：0
|
作者：
Menzin, Andrew
Java, James
Lovecchio, John L.
Chi, Dennis
Tew, William P.
Bookman, Michael A.
Lichtman, Stuart M.
机构：
[1] N Shore Univ Hosp, Manhasset, NY USA
[2] New York State Dept Hlth, Roswell Pk Mem Inst, Gynecol Oncol Grp, Buffalo, NY 14263 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5057
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The impact of interval cytoreduction and age in advanced-stage ovarian cancer: A GOG ancillary study.
    Lichtman, Stuart M.
    Java, James
    Lovecchio, John L.
    Chi, Dennis
    Tew, William P.
    Bookman, Michael A.
    Menzin, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Rethinking of radical surgery at interval debulking surgery for advanced-stage ovarian cancer undergoing neoadjvuant chemotherapy
    Lee, Y. J.
    Lee, J. Y.
    Nam, E. J.
    Kim, S. W.
    Kim, S.
    Kim, Y. T.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 85 - 85
  • [3] Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [4] Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262
    Chan, J. K.
    Brady, M. F.
    Penson, R. T.
    Monk, B. J.
    Kapp, D. S.
    Birrer, M. J.
    Huang, H.
    Walker, J. L.
    DiSilvestro, P. A.
    Rubin, S. C.
    Martin, L. P.
    Davidson, S. A.
    Huh, W. K.
    O'Malley, D. M.
    Boente, M. P.
    Michael, H.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 68 - 68
  • [5] Impact of older age on chemotherapy toxicity and quality of life in women with advanced or recurrent cervical cancer: A NRG Oncology-GOG Ancillary Study.
    Ko, Emily Meichun
    Java, James
    Schmitz, Kathryn
    Randall, Marcus
    Bloss, Jeffrey
    Fleming, Gini F.
    Moore, David H.
    Monk, Bradley J.
    Muss, Hyman B.
    Van Le, Linda
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center
    Mueller, Jennifer J.
    Kelly, Amelia
    Zhou, Qin
    Iasonos, Alexia
    Roche, Kara Long
    Sonoda, Yukio
    O'Cearbhaill, Roisin E.
    Zivanovic, Oliver
    Chi, Dennis S.
    Gardner, Ginger J.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 496 - 503
  • [7] Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
    Lee, Yong Jae
    Seon, Ki Eun
    Jung, Dae Chul
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] INTERVAL DEBULKING SURGERY WITH OR WITHOUT HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN ADVANCED-STAGE OVARIAN CANCER: SINGLE-INSTITUTION COHORT STUDY
    Lee, Yong Jae
    Seon, Kieun
    Kim, Jung Chul
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A153 - A154
  • [9] Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?
    Al Mutairi, Nashmia
    Le, Tien
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2019, 41 (02) : 185 - 190
  • [10] Assessment of peritoneal cytology in advanced-stage ovarian cancer patients at interval debulking surgery
    Kato, K.
    Omatsu, K.
    Nomura, H.
    Matoda, M.
    Matsuura, M.
    Katsuda, T.
    Okamoto, S.
    Kondo, E.
    Kanao, H.
    Utsugi, K.
    Sugiyama, Y.
    Takeshima, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 741 - 741
12345